Browse Title Index


 
Issue Title
 
Vol 8, No 2S (2007) Valutazione economica dello studio PROVE-IT Abstract   PDF
Lorenzo G. Mantovani, Sabato Montella, Anna Citarella, Simona De Portu
 
Vol 8, No 2S (2007) Valutazione economica dello studio TNT Abstract   PDF
Lorenzo G. Mantovani, Sabato Montella, Anna Citarella, Simona De Portu
 
Vol 4, No 2 (2003) Valutazione economica di Infliximab (Remicade®) vs Etanercept (Enbrel®) nel trattamento dell’artrite reumatoide Abstract   PDF
G. L. Colombo, A. Muzio, A. Longhi
 
Vol 6, No 4 (2005) Valutazione farmacoeconomica della prevenzione con picotamide vs acido acetilsalicilico dei pazienti diabetici con vasculopatia periferica Abstract   PDF
Sergio Iannazzo, Lorenzo Pradelli, Mario Eandi
 
Vol 4, No 1 (2003) Valutazione farmacoeconomica dell’uso di tramadolo vs ketorolac nella gestione del dolore postoperatorio Abstract   PDF
Lorenzo G. Mantovani
 
Vol 2, No 3 (2001) Valutazione farmacoeconomica di una casistica di pazienti con riacutizzazione di bronchite cronica Abstract   PDF
M. Liconti, M. Polimeni, C. Filloramo, F. Reale
 
Vol 12, No 2S (2011) Valutazioni economiche di atorvastatina in prevenzione secondaria: un aggiornamento Abstract   PDF
Simona de Portu, Sabato Montella, Paolo Cortesi, Enrica Menditto, Simona Cammarota, Anna Citarella, Lorenzo G. Mantovani
 
Vol 18, No 1 (2017) Varenicline treatment for smoking cessation in high risk patients: a budget impact analysis Abstract   HTML   PDF
Federico Spandonaro, Letizia Mancusi, Barbara Polistena
 
Vol 13, No 2S (2012) Veneto Abstract   HTML   PDF
Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni
 
Vol 9, No 1S (2008) Veneto Abstract   PDF
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi
 
Vol 14, No 3 (2013) Venous thrombo-embolism (VTE) prevention of patients undergoing total hip and knee replacement: budget impact analysis of apixaban in Italy Abstract   HTML   PDF
Lorenzo Giovanni Mantovani, Giovanni Di Minno, Gianluca Furneri
 
Vol 15, No 4 (2014) Venous tromboembolism treatment: budget impact analysis of rivaroxaban in Italy Abstract   HTML   PDF
Daniela Paola Roggeri, Alessandro Roggeri, Vittorio Pengo
 
Vol 13, No 2 (2012) What are key determinants of hospital admissions, readmission rate and day case rate within the South African medical schemes population? Abstract   HTML   PDF
Nondumiso Gugu Khumalo, Michael Willie, Evelyn Thsehla
 
Vol 8, No 2 (2007) Which future for pharmacoeconomics in Italy? Details   PDF
Mario Eandi
 
Vol 17, No 2S (2016) [Budget impact analysis for peginterferon beta-1a in relapsing remitting multiple sclerosis in Italy] Abstract   HTML   PDF
Sergio Iannazzo, Laura Santoni, Cecilia Saleri, Elisa Puma, Giulia Vestri, Luigi Giuliani, Diego Centonze, Pier Luigi Canonico
 
Vol 17, No 1 (2016) [Budget impact analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy] Abstract   HTML   PDF
Gianluca Furneri, Chiara Marchesi, Laura Santoni
 
Vol 17, No 1 (2016) [Budget impact analysis of empagliflozin for the treatment of type 2 diabetes in Italy] Abstract   HTML   PDF
Sergio Iannazzo, Edoardo Mannucci, Lorenzo Mantovani
 
Vol 17, No 2 (2016) [Budget impact analysis of idarucizumab for the management of patients treated with dabigatran in emergency / urgent situations in Italy] Abstract   HTML   PDF
Andrea Belisari, Sergio Iannazzo, Giuseppe Di Pasquale, Claudio Fresco, Lorenzo Giovanni Mantovani, Maria Pia Ruggeri, Danilo Toni, Raffaele Landolfi
 
Vol 17, No 3S (2016) [Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market] Abstract   HTML   PDF
Lorenzo Pradelli, Paolo Ascierto
 
Vol 17, No 2 (2016) [Cost-effectiveness analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy] Abstract   HTML   PDF
Gianluca Furneri, Laura Santoni, Chiara Marchesi, Sergio Iannazzo, Paolo Angelo Cortesi, Achille Patrizio Caputi, Lorenzo Giovanni Mantovani
 
Vol 16, No 4 (2015) [Cost-effectiveness analysis of ocriplasmin in the treatment of vitreomacular traction in Italy] Abstract   HTML   PDF
Lucia Sara D'Angiolella, Riccardo Miglietta, Francesco Bandello, Stanislao Rizzo, Lorenzo Giovanni Mantovani
 
Vol 17, No 2S (2016) [Cost-effectiveness analysis of peginterferon beta-1a in Italian relapsing remitting multiple sclerosis management] Abstract   HTML   PDF
Sergio Iannazzo, Laura Santoni, Cecilia Saleri, Elisa Puma, Giulia Vestri, Luigi Giuliani, Pier Luigi Canonico, Diego Centonze
 
Vol 17, No 2 (2016) [Cost-minimization analysis of replacement therapy in the treatment of von Willebrand disease] Abstract   HTML   PDF
Giancarlo Castaman
 
Vol 18, No 1 (2017) [In reference to "Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”] Details   HTML   PDF
Matteo Ferrario, Giovanni Giuliani
 
Vol 17, No 2 (2016) [Kovaltry® for the replacement therapy in patients with Hemophilia A] Abstract   HTML   PDF
Daniela Paola Roggeri, Alessio Colombo, Alessandro Roggeri
 
Vol 18, No 1S (2017) [Nintedanib for the treatment of idiopathic pulmonary fibrosis in Italy] Abstract   HTML   PDF
Andrea Belisari, Daria Bettoni, Paolo Angelo Cortesi, Lucia Sara D'Angiolella, Lorenzo Giovanni Mantovani, Gerardo Miceli Sopo, Marino Nonis
 
Vol 17, No 3 (2016) [Organizational and financial aspects of the introduction of Botox® in the clinical diagnostic therapeutic process of chronic migraine at a Local Health Unit in Italy] Abstract   HTML   PDF
Francesca Cioffi, Marco Oradei, Rosanna Cerbo, Vittorio Di Pietro, Giovanna Riccioni, Gianni Pardhanani, Eleonora Capannini, Michele Basile
 
Vol 17, No 2S (2016) [Pegylated interferon beta-1a on the Italian market] Abstract   HTML   PDF
Mario Eandi
 
Vol 17, No 2S (2016) [Pegylation and interferons in multiple sclerosis] Abstract   HTML   PDF
Diego Centonze, Elisa Puma, Cecilia Saleri, Giulia Vestri, Sergio Iannazzo, Laura Santoni, Luigi Giuliani, Pier Luigi Canonico
 
Vol 18, No 1 (2017) [Reply to Letter to the Editor in reference to " Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”] Details   HTML   PDF
Lorenzo Pradelli, Paolo Ascierto
 
Vol 18, No 2S (2017) [Tecfidera® (delayed-release dimethylfumarate) in the treatment of relapsing-remitting multiple sclerosis] Abstract   HTML   PDF
Lorenzo Giovanni Mantovani, Gianluca Furneri, Paolo Angelo Cortesi, Maria Pia Amato, Achille Patrizio Caputi, Patrizio Piacentini, Alessandra Solari, Carlo Pozzilli, Giancarlo Comi
 
Vol 18, No 1 (2017) [Use of Kovaltry® in patients with Hemophilia A: clinical and economical aspects from the pivotal clinical trials] Abstract   HTML   PDF
Lucia Sara D'Angiolella, Angelo Claudio Molinari, Paolo Angelo Cortesi, Antonio Coppola, Lorenzo Giovanni Mantovani
 
401 - 432 of 432 Items << < 1 2 3 4 5